iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Decline in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a large decrease in short interest in August. As of August 14th, there was short interest totaling 2,154 shares, a decrease of 73.2% from the July 30th total of 8,033 shares. Based on an average daily volume of 2,286 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.6% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA acquired a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned about 3.01% of iShares Health Innovation Active ETF as of its most recent filing with the Securities and Exchange Commission.

iShares Health Innovation Active ETF Stock Down 0.4%

Shares of iShares Health Innovation Active ETF stock traded down $0.15 during trading on Thursday, hitting $34.50. 1,036 shares of the stock traded hands, compared to its average volume of 3,428. The stock has a market cap of $12.42 million, a price-to-earnings ratio of 24.91 and a beta of 0.73. iShares Health Innovation Active ETF has a 52 week low of $25.79 and a 52 week high of $34.86. The firm’s fifty day moving average is $31.34 and its 200-day moving average is $29.80.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.